drugset / Trial / NCT05845359

Intraoperative Methadone for Postoperative Pain Control

NCT05845359

Phase 4 Withdrawn Montefiore Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare patient pain perception and satisfaction as well as opioid-related side effects during inpatient and outpatient care when undergoing bariatric enhanced recovery after surgery protocols with and without methadone.

Timeline

Start
2023-09
Primary completion
2024-02
Completion
2024-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Methadone Other / unclassified 10 mg

Indications

No indication recorded.